{"cdcTestId":"2013-0201","testcaseName":"Dose 1 to dose 2 interval 28 days","vaccineGroup":"HepB","evaluationTestType":"Interval: At Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-09-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2023-03-08T00:00:00","recommendedDate":"2023-03-21T00:00:00","pastDueDate":"2024-05-18T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2018-02-09T09:36:49.105","generalDescription":"This test case desribes when dose #2 of the Hep B vaccine is administered at an interval of 28 days after dose #1 that the dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}